SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007512
Filing Date
2016-08-05
Accepted
2016-08-05 14:12:52
Documents
50
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ecyt-20160630x10q.htm 10-Q 1214064
2 EX-31.1 ecyt-20160630ex311057bb6.htm EX-31.1 20790
3 EX-32.1 ecyt-20160630ex3210d5b18.htm EX-32.1 8143
  Complete submission text file 0001558370-16-007512.txt   5068993

Data Files

Seq Description Document Type Size
4 EX-101.INS ecyt-20160630.xml EX-101.INS 1282256
5 EX-101.SCH ecyt-20160630.xsd EX-101.SCH 27719
6 EX-101.CAL ecyt-20160630_cal.xml EX-101.CAL 29279
7 EX-101.DEF ecyt-20160630_def.xml EX-101.DEF 81494
8 EX-101.LAB ecyt-20160630_lab.xml EX-101.LAB 254463
9 EX-101.PRE ecyt-20160630_pre.xml EX-101.PRE 207532
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 161810424
SIC: 2834 Pharmaceutical Preparations